Delivery Order SPE2DB20D3303-SPE2DB24FA0ZP

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,781.59, is for the procurement of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used in the treatment of diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of January 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication for the treatment of diabetes. The contract has a ceiling value of $4,383.66 and a period of performance through April 3, 2025. It is a Firm Fixed Price contract, with no set-aside designation indicated. Amerisourcebergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,534.20 and is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, which is a medication used to treat diabetes. The contract is a firm fixed price arrangement and has an ultimate completion date of January 27, 2025. The contract was not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $3,306.10 and is a firm fixed price contract with a period of performance through March 25, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corp...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication used to treat diabetes. The contract has a ceiling value of $1,091.12 and runs through December 30, 2024. This contract award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract has a ceiling value of $1,627.57 and a period of performance through September 24, 2024. This order is placed under an Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with Amerisourcebergen, valued up to $999,999,999 through December 2025, for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medication. The contract has a ceiling value of $1,878.64 and a period of performance through March 6, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,229.56, is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. The contract has a period of performance through September 2023 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,326.23, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has a final completion date of March 19, 2025 and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, with a ceiling value of $1,068.84. The contract has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0ZP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication used for the treatment of diabetes. The contract has a ceiling value of $1,537.64 and a period of performance through July 15, 2024. This order was placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate the use of any set-aside designation, suggesting open competition.

Generated 5/17/25, 10:05 AM